A panel of experts comment on new therapeutic agents being developed and discuss their final thoughts on dry eye disease.
Lisa M. Nijm, MD, JD
Advertisement
Articles by Lisa M. Nijm, MD, JD
Lisa M. Nijm, MD, JD, educates on Eysuvis, an FDA-approved prescription therapeutic for dry eye disease.
The panel discusses the possible prescription treatments for dry eye disease.
A panel of pharmacists and doctors explain when a patient should seek professional help for dry eye disease.
Monazzah Akbar Sarwar, PharmD, continues the conversation for over-the-counter treatment options for patients with dry eye disease.
Brian Walker, RPh, elaborates on the over-the-counter treatment options for patients with dry eye disease.
The panel reflects on the effects COVID-19 has had on their patients with dry eye disease.
A panel of experts discuss how pharmacists can play a role in the nonpharmacologic treatment of dry eye disease.
Lisa M. Nijm, MD, JD, explains dry eye disease and its effects on a suffering patient.
Advertisement
Latest Updated Articles
Over-the-Counter Treatment Options for DED: ContinuedPublished: August 5th 2021 | Updated:
When to Seek Professional Help for DEDPublished: August 6th 2021 | Updated:
Getting to Know DEDPublished: July 22nd 2021 | Updated:
- New Therapeutic Agents and Final Thoughts on DED
Published: August 17th 2021 | Updated:
- DED From the Pharmacist Perspective
Published: July 22nd 2021 | Updated:
- Prescription Treatments for DED
Published: August 10th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
2
Five-Year NATALEE Data Show Ribociclib Improves Outcomes in High-Risk HR+/HER2– Early Breast Cancer
3
TAR-200 Intravesical System Demonstrates Sustained Bladder Exposure in BCG-Unresponsive NMIBC
4
Durvalumab Plus Chemotherapy Sets New Standard in Resectable Gastric and GEJ Cancer
5
